As depicted in Figure 2, attenuation of survivin by the BIRC5 inhibitor is associated with destabilizing microtubules within the G2/M phase, thereby yielding downstream activation of caspase-mediated apoptosis within GBM cells. Here, BIRC5 is linked to glioblastoma.